BackConatus Pharmaceuticals Overview

Conatus Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CNAT.

Quarterly EBIT

-$3.60M
↑ 20.85% YoY

As of Mar 31, 2020

Annual EBIT (TTM)

-$9.87M
↑ 42.04% YoY

Trailing 12 months ending Mar 31, 2020

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin